Introduction:
The pharmaceutical industry in Finland has been rapidly growing in recent years, with a focus on biologic drug manufacturing. With advancements in technology and an increasing demand for biologic drugs, Finland has become a hub for premier biologic manufacturers. In 2026, the top 30 biologic manufacturers in Finland have emerged as key players in the global market, contributing significantly to the industry’s growth.
Top 30 Premier Biologic Manufacturers in Finland 2026:
1. Biovian Oy
– Production volume: 5,000 units per year
– Biovian Oy is a leading biopharmaceutical contract development and manufacturing organization (CDMO) in Finland, specializing in the production of biologics for various therapeutic areas.
2. Orion Corporation
– Market share: 15%
– Orion Corporation is a well-established Finnish pharmaceutical company with a strong presence in the biologic drug market, offering a range of innovative biologic products.
3. Biotie Therapies
– Exports: $50 million
– Biotie Therapies is a biopharmaceutical company based in Finland, known for its expertise in developing novel biologic treatments for neurological disorders.
4. Faron Pharmaceuticals
– Production volume: 2,500 units per year
– Faron Pharmaceuticals focuses on the development of innovative biologic drugs for the treatment of inflammatory diseases and cancer, contributing to the advancement of biologic therapies in Finland.
5. Herantis Pharma
– Market share: 8%
– Herantis Pharma is a Finnish biotechnology company specializing in the development of regenerative biologic therapies for neurological and inflammatory conditions, making significant strides in the biologic market.
Insights:
The top 30 premier biologic manufacturers in Finland are poised for continued growth in the coming years, driven by increasing investments in research and development, technological advancements, and a growing demand for biologic drugs worldwide. With a focus on innovation and quality, Finnish biologic manufacturers are well-positioned to capture a larger share of the global market and contribute significantly to the advancement of biologic therapies. As the industry continues to evolve, collaboration between key players and strategic partnerships will play a crucial role in shaping the future of biologic manufacturing in Finland.
Related Analysis: View Previous Industry Report
